BOOK
Mandell, Douglas and Bennett’s Infectious Disease Essentials E-Book
John E. Bennett | Raphael Dolin | Martin J. Blaser
(2016)
Additional Information
Book Details
Abstract
Brought to you by the expert editor team from Principles and Practice of Infectious Diseases, this brand-new handbook provides a digestible summary of the 241 disease-oriented chapters contained within the parent text. Boasting an exceptionally templated design with relevant tables and illustrations, it distills the essential, up-to-date, practical information available in infectious disease. This high-yield manual-style reference will prove useful for a wide variety of practitioners looking for quick, practical, and current infectious disease information.
- Provides a digestible summary of the 241 disease-oriented chapters contained within Principles and Practice of Infectious Diseases, 8th Edition (ISBN: 978-1-4557-4801-3).
- Covers hot topics in infectious disease, such as Hepatitis B and C, Influenza, Measles, Papillomavirus, HIV, MERS, and C. difficile.
- Templated design includes relevant tables and illustrations.
- Ideal for the non-infectious disease specialist, including primary care physicians, physician assistants, nurse practitioners, students, residents, pharmacists, emergency physicians, and urgent care physicians.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Inside Front Cover | ifc1 | ||
Mandell, Douglas and Bennett's Infectious Disease Essentials | i | ||
Copyright Page | iv | ||
Contributors | v | ||
Preface | xxvii | ||
Table Of Contents | xxix | ||
I Major Clinical Syndromes | 1 | ||
A Fever | 2 | ||
1 Fever of Unknown Origin | 2 | ||
Definition | 2 | ||
Etiology and Epidemiology | 2 | ||
Diagnosis | 2 | ||
Therapy | 2 | ||
Prognosis | 2 | ||
2 The Acutely Ill Patient with Fever and Rash | 3 | ||
Definition | 3 | ||
Epidemiology | 3 | ||
Microbiology | 3 | ||
Diagnosis | 3 | ||
Therapy | 4 | ||
Prevention | 4 | ||
B Upper Respiratory Tract Infections | 5 | ||
3 The Common Cold | 5 | ||
Definition | 5 | ||
Epidemiology | 5 | ||
Microbiology | 5 | ||
Diagnosis | 5 | ||
Therapy | 5 | ||
Prevention | 5 | ||
4 Pharyngitis | 6 | ||
Definition | 6 | ||
Epidemiology | 6 | ||
Microbiology | 6 | ||
Diagnosis | 6 | ||
Therapy | 7 | ||
5 Acute Laryngitis | 10 | ||
Definition | 10 | ||
Epidemiology | 10 | ||
Microbiology | 10 | ||
Diagnosis | 10 | ||
Therapy | 10 | ||
6 Croup in Children (Acute Laryngotracheobronchitis) | 11 | ||
Definition | 11 | ||
Epidemiology | 11 | ||
Etiology and Microbiology | 11 | ||
Diagnosis | 11 | ||
Therapy | 11 | ||
7 Otitis Externa, Otitis Media, and Mastoiditis | 12 | ||
Definition | 12 | ||
II Infectious Diseases and Their Etiologic Agents | 175 | ||
A Viral Diseases | 176 | ||
71 Orthopoxviruses | 176 | ||
Definition | 176 | ||
Epidemiology | 176 | ||
Microbiology | 176 | ||
Diagnosis | 176 | ||
Therapy | 176 | ||
Prevention | 177 | ||
72 Other Poxviruses That Infect Humans | 178 | ||
Definition | 178 | ||
Epidemiology | 178 | ||
Microbiology | 178 | ||
Diagnosis | 178 | ||
Therapy | 178 | ||
Prevention | 178 | ||
73 Herpes Simplex Virus | 179 | ||
Definition | 179 | ||
Epidemiology | 179 | ||
Microbiology | 179 | ||
Clinical Manifestations | 179 | ||
Diagnosis | 180 | ||
Treatment | 180 | ||
74 Chickenpox and Herpes Zoster (Varicella-Zoster Virus) | 183 | ||
Definition | 183 | ||
Epidemiology | 183 | ||
Microbiology | 183 | ||
Diagnosis | 183 | ||
Therapy | 183 | ||
Prevention | 184 | ||
75 Cytomegalovirus (CMV) | 185 | ||
Definition | 185 | ||
Epidemiology | 185 | ||
Microbiology | 185 | ||
Diagnosis | 185 | ||
Therapy | 185 | ||
Prevention | 185 | ||
76 Epstein-Barr Virus (Infectious Mononucleosis, Epstein-Barr Virus–Associated Malignant Diseases, and Other Diseases) | 186 | ||
Definition | 186 | ||
Virology and Epidemiology | 186 | ||
Microbiology | 186 | ||
Clinical Manifestations | 186 | ||
Diagnosis | 186 | ||
Therapy | 187 | ||
Prevention | 187 | ||
77 Human Herpesvirus Types 6 and 7 (Exanthem Subitum) | 188 | ||
Definition | 188 | ||
Epidemiology | 188 | ||
Microbiology | 188 | ||
Diagnosis | 188 | ||
Therapy | 188 | ||
78 Kaposi’s Sarcoma–Associated Herpesvirus (Human Herpesvirus 8) | 189 | ||
Definition | 189 | ||
Virology and Epidemiology | 189 | ||
Microbiology | 189 | ||
Diagnosis | 189 | ||
Therapy | 189 | ||
Prevention | 189 | ||
79 Herpes B Virus | 190 | ||
Definition | 190 | ||
Epidemiology | 190 | ||
Microbiology | 190 | ||
Diagnosis | 190 | ||
Therapy | 190 | ||
Prevention | 190 | ||
80 Adenoviruses | 192 | ||
Definition | 192 | ||
Epidemiology | 192 | ||
Microbiology | 192 | ||
Diagnosis | 192 | ||
Therapy | 193 | ||
Prevention | 193 | ||
81 Papillomaviruses | 194 | ||
Definition | 194 | ||
Epidemiology | 194 | ||
Microbiology | 194 | ||
Diagnosis | 194 | ||
Therapy | 194 | ||
Prevention | 195 | ||
82 JC, BK, and Other Polyomaviruses | 196 | ||
JC Virus | 196 | ||
III Special Problems | 455 | ||
A Nosocomial Infections | 456 | ||
224 Infections Caused by Percutaneous Intravascular Devices | 456 | ||
Definition | 456 | ||
Epidemiology | 456 | ||
Microbiology | 456 | ||
Diagnosis | 456 | ||
Prevention | 456 | ||
225 Nosocomial Pneumonia | 458 | ||
Diagnosis | 458 | ||
Microbiology | 458 | ||
Treatment | 458 | ||
Prevention | 459 | ||
226 Nosocomial Urinary Tract Infections | 460 | ||
Definition | 460 | ||
Epidemiology | 460 | ||
Microbiology | 460 | ||
Diagnosis | 460 | ||
Therapy (See Table 226-1) | 460 | ||
Prevention | 461 | ||
227 Health Care–Acquired Hepatitis | 462 | ||
Definition | 462 | ||
Epidemiology | 462 | ||
Diagnosis | 462 | ||
Postexposure Treatment | 462 | ||
Vaccination | 462 | ||
228 Transfusion- and Transplantation-Transmitted Infections | 463 | ||
Definition | 463 | ||
Epidemiology | 463 | ||
Microbiology | 463 | ||
Diagnosis | 463 | ||
Therapy and Prevention | 463 | ||
B Infections in Special Hosts | 464 | ||
229 Prophylaxis and Empirical Therapy of Infection in Cancer Patients | 464 | ||
Risk Factors for Infections in Cancer Patients | 464 | ||
Epidemiology and Etiology | 464 | ||
Prophylaxis (see Table 229-1) | 464 | ||
Management of Febrile Neutropenia (see Figs. 229-1 and 229-2) | 467 | ||
230 Infections in Recipients of Hematopoietic Stem Cell Transplants | 470 | ||
Types of Donors of Stem Cells for Hematopoietic Stem Cell Transplantation (HSCT) | 470 | ||
Specific Types of Allogeneic Donors | 470 | ||
Types of Cells Used in HSCT | 470 | ||
Preparation of Patient for Cell Infusion (“Conditioning Regimen”) | 470 | ||
Outcomes | 470 | ||
Complications | 471 | ||
Antimicrobial Agents for Prophylaxis | 471 | ||
Preemptive Therapy | 471 | ||
Empirical Antibacterial Therapy during Fever and Neutropenia with Negative Workup | 471 | ||
Viral Diseases in the Transplant Recipient | 472 | ||
Other Infections | 473 | ||
231 Infections in Solid-Organ Transplant Recipients | 474 | ||
Epidemiology | 474 | ||
Types of Infections | 474 | ||
Management | 474 | ||
232 Infections in Patients with Spinal Cord Injury | 475 | ||
Definition | 475 | ||
Prevalence and Etiology | 475 | ||
Urinary Tract Infection | 475 | ||
Pneumonia | 475 | ||
Infection of Pressure Sores and Bone | 475 | ||
Multiresistant Organisms in Spinal Cord Injury Units | 475 | ||
233 Infections in the Elderly | 476 | ||
General Considerations | 476 | ||
Urinary Tract Infection | 476 | ||
Pneumonia | 476 | ||
Bacteremia and Endocarditis | 476 | ||
Central Nervous System Infections | 476 | ||
Immunizations | 476 | ||
234 Infections in Asplenic Patients | 477 | ||
Epidemiology | 477 | ||
Microbiology | 477 | ||
Diagnosis | 477 | ||
Treatment | 477 | ||
Prevention | 477 | ||
235 Infections in Injection Drug Users | 479 | ||
Host Defenses | 479 | ||
Skin and Soft Tissue Infections | 479 | ||
Bone and Joint Infections | 479 | ||
Infective Endocarditis | 480 | ||
Noncardiac Vascular Infections | 480 | ||
Pulmonary Infections | 480 | ||
Hepatitis | 480 | ||
Splenic Abscess | 481 | ||
Central Nervous System Infection | 481 | ||
Ocular Infections | 481 | ||
Human Immunodeficiency Virus Infection | 481 | ||
Sexually Transmitted Diseases | 481 | ||
236 Surgical Site Infections and Antimicrobial Prophylaxis | 482 | ||
Background | 482 | ||
Risk Factors for Surgical Site Infections (See Table 236-1) | 482 | ||
Prevention of Surgical Site Infections (See Table 236-2) | 482 | ||
Surgical Antimicrobial Prophylaxis | 482 | ||
SSI Surveillance | 482 | ||
C Surgical- and Trauma-Related Infections | 486 | ||
237 Burns | 486 | ||
Definitions | 486 | ||
Epidemiology | 486 | ||
238 Bites | 487 | ||
Definition | 487 | ||
Epidemiology | 487 | ||
Microbiology | 487 | ||
Diagnosis | 487 | ||
Therapy | 487 | ||
Prevention | 489 | ||
D Zoonoses | 490 | ||
239 Zoonoses | 490 | ||
Definition | 490 | ||
Epidemiology | 490 | ||
Diagnosis | 490 | ||
Treatment | 490 | ||
Prevention | 490 | ||
E Protection of Travelers | 491 | ||
240 Protection of Travelers | 491 | ||
Perform Risk Assessment | 491 | ||
Administer Immunizations | 491 | ||
Provide Malaria Prevention (If Indicated) | 491 | ||
Traveler’s Diarrhea | 491 | ||
Teach Essential Preventive Behaviors | 491 | ||
Discuss Other Applicable Health Issues | 492 | ||
241 Infections in Returning Travelers | 493 | ||
Major Syndromes in Returned Travelers | 493 | ||
Tropical Diseases with Positive Peripheral Blood Films | 493 | ||
Incubation Periods of Tropical Diseases | 493 | ||
Evaluation of Significant Tropical Fever | 493 | ||
Index | 496 | ||
A | 496 | ||
B | 498 | ||
C | 499 | ||
D | 501 | ||
E | 502 | ||
F | 503 | ||
G | 504 | ||
H | 505 | ||
I | 506 | ||
J | 508 | ||
K | 508 | ||
L | 508 | ||
M | 509 | ||
N | 511 | ||
O | 512 | ||
P | 512 | ||
Q | 515 | ||
R | 515 | ||
S | 516 | ||
T | 518 | ||
U | 519 | ||
V | 519 | ||
W | 520 | ||
Y | 520 | ||
Z | 520 | ||
Inside Back Cover | ibc1 |